Prescription Drugs: Price Trends for Frequently Used Brand and Generic Drugs from 2000 Through 2004
DIANE Publishing, 2009 - 24 pages
Prescription drug (PD) spending has been the fastest growing segment of nat. health expenditures. As the fed. gov┐t. assumes greater financial responsibility for PD expenditures with the intro. of Medicare Part D, fed. policymakers are increasingly concerned about PD prices. This report examines the change in retail prices and other pricing benchmarks for drugs frequently used by Medicare beneficiaries and other individuals with health insur. from 2000-2004. To examine the change in retail prices from 2000-2004, this report obtained usual and customary prices from two state pharmacy assistance programs for PD frequently used by Medicare beneficiaries and non-Medicare enrollees in the 2003 Blue Cross and Blue Shield Fed. Employee Program. Illus.
What people are saying - Write a review
We haven't found any reviews in the usual places.
2000 through December 20mg 30 tablets 30 capsules 30 tablets Brand 30 tablets extended 50 brand drugs 76 prescription drugs Alprazolam AMPs and U&C analysis of data Appendix Atenolol average annual rate average U&C prices AWP index BCBS FEP enrollees BCBS FEP Medicare BCBS FEP non-Medicare beneficiaries and non-Medicare Celebrex data from BCBS DataBank dispensed to BCBS drug’s Drugs Included examine price trends extended release Brand FEP Medicare enrollees frequently used brand Furosemide GAO analysis Isosorbide Mononitrate Lipitor Lorazepam Medicaid Medicare and non-Medicare Medicare beneficiaries Medicare part D non-Medicare enrollees increased Norvasc number of units PACE and EPIC percent average annual Pravachol Prednisone Premarin prescription drugs frequently prescriptions dispensed Prices for 50 prices reported quarter of 2000 quarterly AMP rate of increase release Generic Medicare retail prices Synthroid tablets Brand Medicare tablets extended release tablets Generic Non-Medicare typical 30-day supply U&C and AWP U&C price index Zoloft